Director/PDMR Shareholding

RNS Number : 9987D
Oxford Biomedica PLC
03 May 2013
 



Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons

 

1

Issuer

Oxford BioMedica PLC

2

Reason for notification

Notification relates to DTR 3.1.2R

3

Name of PDMR

Martin Diggle

4

Connected person

Notification relates to following connected persons:

Vulpes Testudo Fund

Vulpes Life Sciences Fund

5

Notification in respect of

Notification in respect of holdings of persons in 4 above

6

Description of shares

Oxford BioMedica PLC ordinary shares of 1p each

7

Name of registered shareholders and number of shares

Vulpes Testudo Fund - 2,942,339 shares

Vulpes Life Sciences Fund - 364,000,000 shares

8

Nature of transaction

Purchase

9

Number of shares acquired

 

Vulpes Testudo Fund - 2,942,339 shares

Vulpes Life Sciences Fund - 2,170,589 shares

10

Percentage of issued class acquired

Vulpes Testudo Fund - 0.21%

Vulpes Life Sciences Fund - 0.15%

11

Shares disposed

N/A

12

Percentage of issued class disposed

N/A

13/14

Price per share of transactions, and date

Vulpes Testudo Fund

2,328,178 shares @ £0.0197, 1 May 2013

614,161 shares @ £0.02 , 2 May 2013

Vulpes Life Sciences Fund

2,170,589 shares @ £0.0197, 1 May 2013

15

Total holding following notification and total percentage holding following notification

Vulpes Testudo Fund - 2,942,339 shares

Vulpes Life Sciences Fund - 364,000,000 shares

26.06%

16

Date issuer informed

3 May 2013




23

Any additional information

None

24

Contact name and telephone number

T. Watts, Chief Financial Officer

Oxford BioMedica

+44 (0)1865 783000

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 

END

 
 

RDSBDGDUGDGBGXX